The Cigna HealthCare Prior Authorization Form for Intravenous Immune Globulin (IVIG) plays a critical role in the administration of IVIG treatment for patients under Cigna HealthCare. This comprehensive document is not just a form but a vital tool ensuring that the necessary and specific criteria for IVIG therapy are meticulously reviewed and met. Its sections encompass a wide array of essential details, starting from provider and patient information, specific medication requested, dosage, and administration frequency, to more in-depth medical and treatment history. The form diligently inquires about prior IVIG treatments, primary and secondary immunodeficiencies, along with detailed diagnostic criteria including immunoglobulin levels and vaccine response results. Additionally, it covers reauthorization criteria, indicating a thorough follow-up mechanism to reassess the ongoing need and effectiveness of the treatment. Notably, the form underlines the importance of a complete submission as any missing information may delay processing or lead to an adverse determination, reflecting Cigna's commitment to a stringent but necessary review process to ensure patient safety and optimal care outcomes. Also, it highlights auxiliary treatment contexts across various medical fields such as neurology, hematology, rheumatologic disorders, infectious disease, and dermatology, thereby showcasing the wide applicability of IVIG therapy across diverse conditions. Cigna’s structured approach in processing these requests, along with their provisions for expedited review in urgent cases, signifies their adherence to a patient-centric service model.
Question | Answer |
---|---|
Form Name | Cigna Ivig Form |
Form Length | 5 pages |
Fillable? | No |
Fillable fields | 0 |
Avg. time to fill out | 1 min 15 sec |
Other names | cigna retro authorization form, cigna medicare part b prior authorization, cigna healthcare prior ivig form, cigna ivig form |
Pharmacy Services
Phone:
Fax:
CIGNA HealthCare Prior Authorization Form
- IVIG (Intravenous Immune Globulin)-
Notice: Failure to complete this form in its entirety may result in delayed
processing or an adverse determination for insufficient information.
|
|
PROVIDER INFORMATION |
|
|
|
|
PATIENT INFORMATION |
|
|
|||
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Provider Name: |
|
|
|
|
**Due to privacy regulations we will not be able to respond via |
|
||||
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
fax with the outcome of our review unless all asterisked (*) |
|
||||
|
|
Specialty: |
* DEA or TIN: |
|
|
|
||||||
|
|
|
|
items on this form are completed** |
|
|
||||||
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Office Contact Person: |
|
|
|
|
* Patient Name: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Office Phone: |
|
|
|
|
* CIGNA ID: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Office Fax: |
|
|
|
|
* Date Of Birth: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Is your fax machine kept in a secure location? |
Yes |
No |
|
* Patient Street Address: |
|
|
||||
|
|
|
|
|
|
|
|
|
||||
|
|
* May we fax our response to your office? |
|
Yes |
No |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Office Street Address: |
|
|
|
|
City |
|
State |
|
Zip |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
City
State
Zip
Patient Phone:
Medication requested:
Gamimune N
Carimune
Baygam
Gammar
Carimune NF
Flebogamma
Polygam S/D
Panglobulin NF
Iveegam EN
Gammagard S/D
Other (Please specify):
Gammagard Liquid Immune Globulin, Gamma
Dose requested: |
Dose (mg/kg): |
JCode: |
CPT Code: |
Frequency of administration: |
Duration of therapy: |
|
Patient’s current weight: |
Where will this medication be obtained?
CIGNA
Prescriber’s office stock (billing on a medical claim form) Home Health / Home Infusion vendor (name):
Retail pharmacy Other (please specify):
Address:TIN#:
Please specify the following:
Has this patient been treated with IVIG in the past? Yes No
If Yes, please complete reauthorization criteria in addition to the diagnosis specific criteria on this form.
1. Primary Immunodeficiency
Congenital /
Autosomal recessive agammaglobinulinemia – (ARA)
Autosomal recessive
Congenital Hypogammaglobulinemia
ICF Syndrome
Common variable immunodeficiency (CVID)
Selective IgA Deficiency
Selective IgG subclass deficiencies (IGGSD)
Intravenous Immune Globulin for CIGNA Healthcare Individuals – Page 1 of 5
Specific Antibody Deficiency (SAD)
Transient hypogammaglobulinemia of infancy
Hypogammaglobulinemia, unspecified
Severe combined immunodeficiency disorder (SCID)
Wiskott Aldrich syndrome (WAS)
DiGeorge syndrome (DGS)
(WHIM) warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis
Defects of
Other (please specify):
Pre Treatment Immunoglobulin levels copies of lab reports required, including: Total immunoglobulin levels:
Ig G subclasses (if applicable):
B cells (if applicable):
Genetic testing confirming the diagnosis (if applicable):
Vaccine response results
copies of lab reports required, including
pre & post vaccination responses for pneumococcal, diphtheria, tetanus vaccines
Details of recurrent infections
copies of clinical records required that address the following: Sites of infections:
When did the infections start?
How many episodes per year?
How many courses of antibiotics per year?
List of the names of antibiotics and durations:
Are underlying conditions such as asthma, allergic rhinitis under control? Yes No
Supporting diagnostic imaging or lab results of recurrent infections where applicable:
For reauthorization requests
copies of clinical records required, including: Trough Ig G levels:
Response to IVIG:
2.Secondary Immunodeficiency
Multiple Myeloma
copies of clinical records and lab reports required: Has the disease been stable for 3 months? Yes No Pre treatment Ig G level:
Number of recurrent sino pulmonary infections per year:
CLL
copies of clinical records and lab reports required: Pre treatment Ig G level:
Number of recurrent sino pulmonary infections per year:
Intravenous Immune Globulin for CIGNA Healthcare Individuals – Page 2 of 5
Allogeneic hematopoietic stem cell transplant (HSCT) copies of clinical records and lab reports required: Date of transplant:
Pre treatment Ig G levels:
Number of recurrent sino pulmonary infections per year:
Allosensitized solid organ transplants
Bone marrow transplantation
Date of transplant:
HIV
CD 4 counts:
Current antiretroviral medications:
|
|
3. Hematology |
|
|
|
|
|
|
|
|
|
|
Acute Idiopathic Thrombocytopenic Purpura (ITP) |
|
|
|
|
|
Is there active bleeding? Yes |
No |
|
|
|
|
What is the platelet count? |
Date: |
|
|
|
|
Are there any major surgical procedures planned? Yes |
No |
Date: |
|
Chronic Idiopathic Thrombocytopenic Purpura (ITP) |
|
|
|
copies of clinical records and lab reports required: |
|
|
|
What is the duration of ITP? |
|
|
|
Are there any other concurrent illness/disease explaining thrombocytopenia? |
Yes |
No |
|
Was there prior treatment with a reasonable course of corticosteroids or splenectomy? |
Yes |
||
If Yes, please specify which drugs were tried and the treatment dates: |
|
|
|
What is the platelet count? |
Date: |
|
|
No
|
|
|
|
|
|
|
||||
copies of clinical records and lab reports required |
|
|
|
|
|
|||||
Is there active bleeding? |
Yes |
|
No |
|
|
|
|
|
|
|
What is the current platelet count? |
|
|
Date: |
|
|
|
|
|||
Are there any major surgical procedure planned? |
Yes |
No |
Date: |
|
|
|||||
|
|
|
|
|
|
|
||||
Fetal Alloimmune Thrombocytopenia (FAIT) |
|
|
|
|
|
|
||||
Is there a documentation of maternal antibodies to paternal platelet antigen? Yes |
No |
|
||||||||
Are there any previous pregnancies complicated by FAIT? |
Yes |
No |
|
|
||||||
Fetal platelet counts if available: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Idiopathic Thrombocytopenic Purpura (ITP) in pregnancy |
|
|
|
|
||||||
Is there a history of previously delivered infant(s) with autoimmune thrombocytopenia? Yes |
No |
|||||||||
What is the current platelet count? |
|
|
|
|
|
|
|
|
||
LMP: |
|
|
|
|
|
|
|
|
|
|
Is there any bleeding? |
Yes |
No |
|
|
|
|
|
|
|
|
Is the thrombocytopenia refractory to steroids? |
Yes |
No |
|
|
|
|
||||
Is there a history of splenectomy? |
|
Yes |
No |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|||
Neonatal isoimmune hemolytic disease |
|
|
|
|
|
|
|
|||
Is IVIG given in conjunction with phototherapy? |
Yes |
No |
|
|
|
|
||||
|
|
|
|
|
|
|
||||
Warm type autoimmune hemolytic anemia |
|
|
|
|
|
|
||||
Is there a predominance of Ig G (warm) antibodies? Yes |
No |
|
|
|
||||||
Is there a failure, contraindication, or intolerance to available alternative therapies? |
Yes |
No |
||||||||
If Yes, please mark all that apply: |
|
|
|
|
|
|
|
|
|
|
azathioprine |
|
|
cyclophosphamide |
|
cyclosporine |
|
||||
prednisone |
|
|
plasmapheresis |
|
splenectomy |
other (please specify): |
||||
|
|
|
|
|
|
|
|
|
|
|
Intravenous Immune Globulin for CIGNA Healthcare Individuals – Page 3 of 5
|
Anemia related to chronic parvovirus B19 infection |
|
|
|
||
|
What is the hemoglobin? |
|
|
|
|
|
|
Is there evidence of viremia? Yes |
No |
|
|
|
|
|
|
|
|
|
|
|
|
Evan’s syndrome |
|
|
|
|
|
|
Is there a failure, contraindication, or intolerance to available alternative therapies? Yes |
No |
||||
|
If Yes, please mark all that apply: |
|
|
|
|
|
|
azathioprine |
cyclophosphamide |
cyclosporine |
prednisone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4. Neurology
Neuropathies:
Acute inflammatory demyelinating polyneuropathy (AIDP) Chronic inflammatory demyelinating polyneuropathy (CIDP)
Multifocal acquired demyelinating sensory and motor neuropathy (MADSAM) (Lewis Sumner Syndrome) Multifocal Motor Neuropathy (MMN)
Copies of clinical records and lab reports required that includes the following:
Comprehensive H&P including duration of symptoms and detailed neurological examination
Copy of NCV/EMG reports
CSF results including CSF protein, cell count and VDRL
Other pertinent tests if applicable, e.g., antibody testing, IPEP, imaging studies
For reauthorization requests:
Please provide updated progress notes that includes the following information
Symptoms and objective exam findings such as strength measurement, sensory testing and reflexes and level of function
Titration efforts since last renewal
Updated test results (e.g., if NCV/EMG has been repeated)
Myasthenia gravis |
|
|
copies of clinical records and lab reports required: |
|
|
Is a thymectomy planned or has the individual undergone thymectomy? Yes |
No |
|
If Yes, on what date? |
|
|
Is the individual initiating immunosuppressive treatment? Yes |
No |
|
If Yes, which therapy? |
|
|
If the request is for the treatment of acute crisis, please provide clinical documentation of physical findings indicative of acute crisis.
copies of clinical records and lab / Xray reports required supporting diagnosis and failure of standard therapy: Is there any failure, contraindication, or intolerance to standard conventional therapies (e.g. interferon beta, glatiramer)?
|
|
|
|
Yes |
No |
|
|
|
|
|
|
|
If so, which therapies? |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
What was the date of the initial onset of symptoms? |
|
|
|
|
|
|
|
|
Is the individual currently on plasmapheresis? Yes |
No |
|
|
|
|
|
|
|
|
|
|
|
|
Is there any failure, contraindication, or intolerance to other symptomatic therapies (e.g., acetylcholinesterase inhibitors
such as mestinon and immunosuppressants such as prednisone, azathioprine)? Yes |
No |
|
|
If so, which therapies? |
|
Stiff Person Syndrome
Prior failure, contraindication, or intolerance to available standard medical therapy (please mark all that apply):
diazepam |
baclofen |
phenytoin |
clonidine |
tizanidine |
Other (please specify): |
Intravenous Immune Globulin for CIGNA Healthcare Individuals – Page 4 of 5
5. Rheumatologic Disorders
Dermatomyositis or Polymyositis
copies of clinical records and lab reports required Please provide biopsy results;
Does the individual have any failure of standard medical therapy (at least a 4 month trial of corticosteroids and/or
immunosuppressants)? Yes |
No |
Is there any profound, rapidly progressive and/or potentially life threatening muscular weakness (refractory or intolerant
to previous therapy)? Yes |
No |
Please provide serum creatine kinase (CK) levels
Please provide any muscle strength scales
Kawasaki disease
What was the date of the onset of symptoms? Will IVIG be used in conjunction with aspirin?
Yes
No
6. Infectious Disease
Staphylococcal or streptococcal toxic shock syndrome
Is the infection refractory to treatment? |
Yes |
No |
If Yes, what therapies have been tried? |
|
|
Is an undrainable focus present? Yes |
No |
|
Is persistent oliguria with pulmonary edema present? Yes
No
Has the individual been exposed to measles or live in a
Yes
No
Hepatitis A
Is intramuscular gamma globulin contraindicated? Yes No If Yes, what is the contraindication?
Tetanus / Varicella
Is Tetanus or Varicella Immune Globulin available? Yes No
7. Dermatology
Pemphigus
Pemphigoid
Epidermolysis Bullosa Acquisita
Is there a failure, contraindication, or intolerance to available alternative therapies? If Yes, please mark all that apply:
corticosteroids CellCept
Yes
No
Does the individual have rapidly progressive disease in which a clinical response can not be affected quickly enough using conventional agents? Yes No
CIGNA HealthCare’s coverage position on this and other medications may be viewed online at:
http://www.cigna.com/customer_care/healthcare_professional/coverage_positions
Please fax completed form to
Our standard response time for prescription drug coverage requests is
“CIGNA Pharmacy Management” or “CIGNA HealthCare” refer to various operating subsidiaries of CIGNA Corporation. Products and services are provided by these subsidiaries and not by CIGNA Corporation. These subsidiaries include Connecticut General Life Insurance Company,
V 041510
Intravenous Immune Globulin for CIGNA Healthcare Individuals – Page 5 of 5